Basel, Switzerland
EsoCap AG is developing a unique targeted application platform technology to treat patients suffering from diseases of the upper gastrointestinal tract. Our drug delivery technology enables targeted and long-lasting local therapy of the esophagus for the first time.
Heidelberg, Germany
We develop small molecule sec61 modulators to treat GI cancers and other severe diseases
Berlin, Germany
Refoxy is the first biotech company purposely developing activators of the transcription factor FOXO3 in order to harness its therapeutic potential in multiple diseases.
Düsseldorf, Germany
We help substrate producers to retain water in their peat-free substrates.
Aachen, Germany
ICHORtec developed FMB® technology – Quantum Science for Molecular Diagnostic. Scientific and Commercial game changer at point of care.
Bad Doberan, Germany
Cell2Green – A recyclable, biodegradable, additive-free packaging film made from renewable raw materials using an environmentally friendly process.